Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey.
JOURNAL OF CLINICAL ONCOLOGY, vol.38, no.15, 2020 (Journal Indexed in SCI)
Article / Abstract
Title of Journal :
JOURNAL OF CLINICAL ONCOLOGY